BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chang S, Huang J, Niu H, Wang J, Si Y, Bai Z, Cheng S, Ding W. Epigenetic regulation of osteopontin splicing isoform c defines its role as a microenvironmental factor to promote the survival of colon cancer cells from 5-FU treatment. Cancer Cell Int 2020;20:452. [PMID: 32944000 DOI: 10.1186/s12935-020-01541-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Fu C, Zhang K, Wang M, Qiu F. Casticin and chrysosplenol D from Artemisia annua L. induce apoptosis by inhibiting topoisomerase IIα in human non-small-cell lung cancer cells. Phytomedicine 2022;100:154095. [DOI: 10.1016/j.phymed.2022.154095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Gopinath P, Natarajan A, Sathyanarayanan A, Veluswami S, Gopisetty G. The multifaceted role of Matricellular Proteins in health and cancer, as biomarkers and therapeutic targets. Gene 2022;815:146137. [PMID: 35007686 DOI: 10.1016/j.gene.2021.146137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Gimeno-valiente F, López-rodas G, Castillo J, Franco L. Alternative Splicing, Epigenetic Modifications and Cancer: A Dangerous Triangle, or a Hopeful One? Cancers 2022;14:560. [DOI: 10.3390/cancers14030560] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Azwar S, Seow HF, Abdullah M, Faisal Jabar M, Mohtarrudin N. Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment. Biology (Basel) 2021;10:854. [PMID: 34571731 DOI: 10.3390/biology10090854] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
5 Amilca-Seba K, Sabbah M, Larsen AK, Denis JA. Osteopontin as a Regulator of Colorectal Cancer Progression and Its Clinical Applications. Cancers (Basel) 2021;13:3793. [PMID: 34359694 DOI: 10.3390/cancers13153793] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
6 Shirakawa K, Sano M. Osteopontin in Cardiovascular Diseases. Biomolecules 2021;11:1047. [PMID: 34356671 DOI: 10.3390/biom11071047] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
7 Huang J, Hu M, Niu H, Wang J, Si Y, Cheng S, Ding W. Osteopontin isoform c promotes the survival of cisplatin-treated NSCLC cells involving NFATc2-mediated suppression on calcium-induced ROS levels. BMC Cancer 2021;21:750. [PMID: 34187410 DOI: 10.1186/s12885-021-08495-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Wang J, Wang C, Li L, Yang L, Wang S, Ning X, Gao S, Ren L, Chaulagain A, Tang J, Wang T. Alternative splicing: An important regulatory mechanism in colorectal carcinoma. Mol Carcinog 2021;60:279-93. [PMID: 33629774 DOI: 10.1002/mc.23291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Gagliano T, Brancolini C. Epigenetic Mechanisms beyond Tumour-Stroma Crosstalk. Cancers (Basel) 2021;13:914. [PMID: 33671588 DOI: 10.3390/cancers13040914] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]